Mukka Proteins Ltd

Integrated Filing — Corporate Governance (NSE XBRL)

Company Home Dashboard NSE Viewer

Filing Summary

Company
Mukka Proteins Limited
Symbol
MUKKA
Quarter Ended
31-Mar-2026
Submission
New

General Disclosures

Advertisements As Per Regulation471
Yes
Annual Return As Provided Under Section92Of The Companies Act2013
Yes
Approval For Material Related Party Transactions
Yes
Approval Of The Board And Shareholders For Compensation Or Profit Sharing
Not Applicable
Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls
Yes
Board Composition
Yes
Code Of Conduct
Yes
Compliance Certificate
Yes
Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation
Yes
Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46
Yes
Credit Rating Or Revision In Credit Rating Obtained
Yes
Date Of End Of Financial Year
31-Mar-2026
Date Of End Of Reporting Period
31-Mar-2026
Date Of Signing
23-Apr-2026
Date Of Start Of Financial Year
01-Apr-2025
Designation Of Person
CEO
Designation Of Person Affirmations
CEO
Designation Of Person For Annual Affirmations
CEO
Designation Of Person For Quartely Affirmations
CEO
Details Of Agreements Entered Into With The Media Companies And Or Their Associates
Not Applicable
Details Of Business
Yes
Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy
Yes
Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30
Yes
Disclosure Of Related Party Transactions On Consolidated Basis
Yes
Disclosure Web Link Of Annual Return As Provided Under Section92Of The Companies Act2013Is Placed
https://mukkaproteins.com/annual-return/
Disclosure Web Link Of Audio Or Video Recordings And Transcripts Of Post Earinings Or Quarterly Calls Is Placed
https://mukkaproteins.com/schedule-of-analyst-or-investor-meet/
Disclosure Web Link Of Company At Advertisements As Per Regulation471Is Placed
https://mukkaproteins.com/disclosure-under-regulation-30-of-sebi-listing-regulations/
Disclosure Web Link Of Company At Dividend Distribution Policy As Per Regulation43A1Is Placed
https://mukkaproteins.com/policies/
Disclosure Web Link Of Company At Materiality Policy As Per Sub Regulation4Regulation30Is Placed
https://mukkaproteins.com/policies/
Disclosure Web Link Of Company At Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity Is Placed
https://mukkaproteins.com/financial-results/
Disclosure Web Link Of Company At Which Credit Rating Or Revision In Credit Rating Obtained Is Placed
https://mukkaproteins.com/credit-rating/
Disclosure Web Link Of Company At Which Details Of Business Is Placed
https://mukkaproteins.com/
Disclosure Web Link Of Company At Which Details Of Establishment Of Vigil Mechanism Or Whistle Blower Policy Is Placed
https://mukkaproteins.com/policies/
Disclosure Web Link Of Company At Which Financial Results Is Placed
https://mukkaproteins.com/financial-results/
Disclosure Web Link Of Company At Which Policy For Determining Material Subsidiaries Is Placed
https://mukkaproteins.com/policies/
Disclosure Web Link Of Company At Which Policy On Dealing With Related Party Transactions Is Placed
https://mukkaproteins.com/policies/
Disclosure Web Link Of Company At Which Shareholding Pattern Is Placed
https://mukkaproteins.com/shareholding-pattern/
Disclosure Web Link Of Compliance With Sub Regulation3Of Regulation46With Respect To Accuracy Of Disclosures On The Website And Timely Updation Is Placed
https://mukkaproteins.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/
Disclosure Web Link Of Confirmation That The Disclosures Are In A Separate Section As Specified In Sub Regulation2Of Regulation46Is Placed
https://mukkaproteins.com/disclosures-under-regulation-46-of-sebi-lodr-regulations/
Disclosure Web Link Of Disclosure Of Contact Details Of KMP Who Are Authorized For The Purpose Of Determining Materiality Under Sub Regulation5Of Regulation30Is Placed
https://mukkaproteins.com/investor-contact-2/
Disclosure Web Link Of Disclosures Under Sub Regulation8Of Regulation30Is Placed
https://mukkaproteins.com/disclosure-under-regulation-30-of-sebi-listing-regulations/
Disclosure Web Link Of Memorandum Of Association And Articles Of Association Is Placed
https://mukkaproteins.com/policies/
Disclosure Web Link Of Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet Is Placed
https://mukkaproteins.com/schedule-of-analyst-or-investor-meet/
Disclosure Web Link Of Secretarial Compliance Report Is Placed
https://mukkaproteins.com/annual-secretarial-compliance-report/
Disclosure Web Link Of Statements Of Deviations Or Variations As Specified In Regulation32Is Placed
https://mukkaproteins.com/statement-of-deviations-or-variations/
Disclosures Under Sub Regulation8Of Regulation30
Yes
Dividend Distribution Policy As Per Regulation43A1
Yes
Employee Benefit Scheme Documents Framed In Terms Of SEBI Share Based Employee Benefits And Sweat Equity Regulations2021
Not Applicable
Fees Or Compensation
Yes
Financial Results
Yes
Is SCORESID Available
Yes
ISIN
INE0CG401037
Market Capitalisation As Per Immediate Previous Financial Year
Top 2000 listed entities
Materiality Policy As Per Sub Regulation4Regulation30
Yes
Memorandum Of Association And Articles Of Association
Yes
Minimum Information
Yes
MSEI Symbol
NOTLISTED
Name Of Signatory
Kalandan Mohammed Haris
Name Of Signatory Affirmations
Kalandan Mohammed Haris
Name Of Signatory For Annual Affirmations
Kalandan Mohammed Haris
Name Of Signatory For Quartely Affirmations
Kalandan Mohammed Haris
Name Of The Company
Mukka Proteins Limited
New Name And The Old Name Of The Listed Entity
Not Applicable
Other Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity
Yes
Place
Mangalore
Plans For Orderly Succession For Appointments
Yes
Policy For Determining Material Subsidiaries
Yes
Policy For Related Party Transaction
Yes
Policy On Dealing With Related Party Transactions
Yes
Reason For Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Not Applicable To The Entity
There are no reportable events during the quarter.
Recommendation Of Board
Yes
Reporting Quarter
Yearly
Review Of Compliance Reports
Yes
Risk Assessment And Management
Yes
Schedule Of Analyst Or Institutional Investor Meet And Presentation Prepared By Listed Entity For Analyst Or Institutional Investor Meet
Yes
SCORES Registration ID
COMM00987
Scrip Code
544135
Secretarial Compliance Report
Yes
Separate Audited Financial Statements Of Each Subsidiary Of The Listed Entity
Yes
Shareholding Pattern
Yes
Statements Of Deviations Or Variations As Specified In Regulation32
Yes
Symbol
MUKKA
The Listed Entity Has Approved Material Subsidiary Policy And The Corporate Governance Requirements With Respect To Subsidiary Of Listed Entity Have Been Complied
Yes
Type Of Company
Equity
Type Of Submission
Original
Vacancies In Respect Key Managerial Personnel
Yes
Vigil Mechanism
Yes
Whether As Per Sub Regulation2ba Of Regulation27Of SEBILODR There Has Been Cyber Security Incidents During The Quarter
No
Whether Part A Of Annexure I Of The SEBI Circular Dated31December2024Related To Compliance Report On Corporate Governance Is Applicable To The Entity
Yes
Whether Part F Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Loans Or Guarantees Or Comfort Letters Or Securities Etc Is Applicable To The Entity
No

Additional Disclosures

Entry D_MeetingBOD1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingBOD3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit1
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit2
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit3
Whether Requirement Of Quorum Met
Yes
Entry D_MeetingComit4
Whether Requirement Of Quorum Met
Yes
Official NSE disclosure viewer

If the viewer does not load, use the NSE Viewer button above to open it in a new tab.

Board Composition — Entity Disclosures

The Composition Of Board Of Directors Is In Terms Of Sebi Regulations2015
Yes
Chairperson Related to MD / CEO
No
Regular Chairperson
Yes

Composition of Board of Directors

SrTitleDirectorPANDINCategory 1Category 2Category 3Date of BirthDisqualifiedStatusSpecial ResolutionSpecial Resolution DateInitial AppointmentRe-appointmentTenure (months)Listed DirectorshipsIndependent DirectorshipsAudit / Stakeholder MembershipsAudit / Stakeholder Chair Posts
1MrMOHAMMED HARIS K******03020471Executive DirectorNot ApplicableCEO-MD19-Jan-1975NoActiveNot Applicable04-Nov-201020-Jan-20222021
2MrKALANDAN MOHAMMED ALTHAF******03051103Executive DirectorNot Applicable07-Dec-1979NoActiveNot Applicable04-Nov-201020-Jan-20222010
3MrK MOHAMMAD ARIF******03020564Executive DirectorNot Applicable15-Jan-1975NoActiveNot Applicable04-Nov-201020-Jan-20222010
4MrKALANDAN ABDUL RAZAK******02530917Non-Executive - Non Independent DirectorNot Applicable08-Sep-1943NoActiveYes15-Jun-202422-Feb-20211011
5MrsUMAIYYA BANU******03051040Non-Executive - Non Independent DirectorNot Applicable05-Jan-1958NoActiveNot Applicable04-Nov-20101000
6MrBALACHANDRA RAO K S******03589394Non-Executive - Independent DirectorChairperson16-Apr-1954NoActiveNot Applicable15-Jan-202215-Jan-202250.172221
7MrHAMAD BAVA******09448423Non-Executive - Independent DirectorNot Applicable25-May-1952NoActiveNot Applicable15-Jan-202215-Jan-202250.172210
8MrNARENDRA SURENDRA KAMATH******07255904Non-Executive - Independent DirectorNot Applicable10-Jun-1965NoActiveNot Applicable15-Jan-202215-Jan-202250.172231

Committee Disclosures

Entry CompComit122
Date of Appointment
17-Jan-2022
Entry CompComit123
Date of Appointment
17-Jan-2022
Entry CompComit124
Date of Appointment
13-Apr-2017
Entry CompComit14
Date of Appointment
17-Jan-2022
Entry CompComit15
Date of Appointment
17-Jan-2022
Entry CompComit16
Date of Appointment
04-Apr-2020
Entry CompComit41
Date of Appointment
17-Jan-2022
Entry CompComit42
Date of Appointment
17-Jan-2022
Entry CompComit43
Date of Appointment
04-Apr-2020
Entry CompComit68
Date of Appointment
17-Jan-2022
Entry CompComit69
Date of Appointment
17-Jan-2022
Entry CompComit70
Date of Appointment
17-Jan-2022
Entry MainD
Composition And Role Of Risk Management Committee
Not Applicable
Composition Of Audit Committee
Yes
Composition Of Nomination And Remuneration Committee
Yes
Composition Of Stakeholder Relationship Committee
Yes
Composition Of Various Committees Of Board Of Directors
Yes
Disclosure Web Link Of Company At Which Composition Of Various Committees Of Board Of Directors Is Placed
https://mukkaproteins.com/committees/
Memberships In Committees
Yes
Prior Or Omnibus Approval Of Audit Committee For All Related Party Transactions
Yes
Risk Management Committee
No
Role Of Audit Committee And Information To Be Reviewed By The Audit Committee
Yes
Role Of Nomination And Remuneration Committee
Yes
Role Of Stakeholders Relationship Committee
Yes
The Committee Members Have Been Made Aware Of Their Powers Role And Responsibilities As Specified In Sebi Regulations2015
Yes
The Composition Of Audit Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Nomination And Remuneration Committee Is In Terms Of Sebi Regulations2015
Yes
The Composition Of The Risk Management Committee Is In Terms Of Sebi Regulations2015
Not Applicable
The Composition Of The Stakeholders Relationship Committee Committee Is In Terms Of Sebi Regulations2015
Yes
Whether The Audit Committee Has A Regular Chairperson
Yes
Whether The Corporate Social Responsibility Committee Has A Regular Chairperson
Yes
Whether The Nomination And Remuneration Committee Has A Regular Chairperson
Yes
Whether The Stakeholders Relationship Committee Has A Regular Chairperson
Yes

Audit Committee

Additional Position
Chairperson
Director DIN
03589394
Member Name
BALACHANDRA RAO K S
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
09448423
Member Name
HAMAD BAVA
Position
Non-Executive - Independent Director

Audit Committee

Additional Position
Member
Director DIN
03051103
Member Name
KALANDAN MOHAMMED ALTHAF
Position
Executive Director

Audit Committee

Audit Committee

Corporate Social Responsibility Committee

Additional Position
Chairperson
Director DIN
09448423
Member Name
HAMAD BAVA
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
03589394
Member Name
BALACHANDRA RAO K S
Position
Non-Executive - Independent Director

Corporate Social Responsibility Committee

Additional Position
Member
Director DIN
03020564
Member Name
K MOHAMMAD ARIF
Position
Executive Director

Nomination and remuneration committee

Additional Position
Chairperson
Director DIN
07255904
Member Name
NARENDRA SURENDRA KAMATH
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
09448423
Member Name
HAMAD BAVA
Position
Non-Executive - Independent Director

Nomination and remuneration committee

Additional Position
Member
Director DIN
02530917
Member Name
KALANDAN ABDUL RAZAK
Position
Non-Executive - Non Independent Director

Nomination and remuneration committee

Stakeholders Relationship Committee

Additional Position
Chairperson
Director DIN
02530917
Member Name
KALANDAN ABDUL RAZAK
Position
Non-Executive - Non Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
07255904
Member Name
NARENDRA SURENDRA KAMATH
Position
Non-Executive - Independent Director

Stakeholders Relationship Committee

Additional Position
Member
Director DIN
03020471
Member Name
MOHAMMED HARIS K
Position
Executive Director

Stakeholders Relationship Committee

Entry MainD
Gap Between The Meetings Of The Risk Management Committee
Not Applicable
Meeting Of Audit Committee
Yes
Meeting Of Board Of Directors
Yes
Meeting Of Independent Directors
Yes
Meeting Of Nomination And Remuneration Committee
Yes
Meeting Of Risk Management Committee
Not Applicable
Meeting Of Stakeholders Relationship Committee
Yes
Quorum Of Board Meeting
Yes
Quorum Of Nomination And Remuneration Committee Meeting
Yes
Quorum Of Risk Management Committeemeeting
Not Applicable
The Meetings Of The Board Of Directors And The Above Committees Have Been Conducted In The Manner As Specified In Sebi Regulations2015
Yes
Entry MeetingBOD1
Dates Of Meeting In The Previous Quarter
12-Nov-2025
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD2
Dates Of Meeting In The Previous Quarter
16-Dec-2025
Maximum Gap Between Any Two Consecutive Meetings
33
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingBOD3
Dates Of Meeting If Any In The Relevant Quarter
12-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
57
Number Of Directors Present In Meeting Of Board Of Directors
8
Number Of Independent Directors Attending The Meeting
3
Total Number Of Directors As On Date Of The Meeting
8
Entry MeetingComit1
Dates Of Meeting Of The Committee In The Previous Quarter
12-Nov-2025
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit2
Dates Of Meeting Of The Committee In The Relevant Quarter
12-Feb-2026
Maximum Gap Between Any Two Consecutive Meetings
91
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit3
Dates Of Meeting Of The Committee In The Relevant Quarter
12-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
2
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MeetingComit4
Dates Of Meeting Of The Committee In The Relevant Quarter
12-Feb-2026
Number Of Director Present In Meeting Of Committee All Directors Including Independent Director
3
Number Of Independent Director Attending Meeting Of Committee
1
Number Of Member Attending Meeting Of Committee
0
Total Number Of Directors As On Date Of The Meeting
3
Entry MainD
Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances
Yes
Disclosure Web Link Of Company At Which Contact Information Of The Designated Officials Of The Listed Entity Who Are Responsible For Assisting And Handling Investor Grievances Is Placed
https://mukkaproteins.com/investor-contact-2/
Disclosure Web Link Of Company At Which Email Address For Grievance Redressal And Other Relevant Details Is Placed
https://mukkaproteins.com/investor-contact-2/
Email Address For Grievance Redressal And Other Relevant Details
Yes
No Of Investor Complaints Disposed Off During The Period
0
No Of Investor Complaints During The Period
0
No Of Investor Complaints Received During The Period
0
Whether Part B Of Annexure I Of The SEBI Circular Dated31December2024Related To Investor Grievance Redressal Report Is Applicable To The Entity
Yes
Entry MainI
No Of Investor Complaints
0
Entry PY_I
No Of Investor Complaints
0
Entry D_AcquisitionShares1
Percentage Of Shares Or Voting Rights Acquired During The Quarter
0.2599
Entry D_AcquisitionShares2
Percentage Of Shares Or Voting Rights Acquired During The Quarter
0.02
Entry I_AcquisitionShares_PY1
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0.7401
Entry I_AcquisitionShares_PY2
Percentage Of Aggregate Holding Of Shares Or Voting Rights
0.98
Entry I_AcquisitionShares1
Date Of Acquisition
23-Feb-2026
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
Ento Proteins Private Limited
Percentage Of Aggregate Holding Of Shares Or Voting Rights
1
Entry I_AcquisitionShares2
Date Of Acquisition
30-Mar-2026
Name Of The Unlisted Company In Which Shares Or Voting Rights Have Been Acquired
Haris Marine Products Private Limited
Percentage Of Aggregate Holding Of Shares Or Voting Rights
1
Entry MainD
Composition Of Board Of Directors Of Unlisted Material Subsidiary
Not Applicable
Whether Part C Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Acquisition Of Shares Or Voting Rights In Unlisted Companies Is Applicable To The Entity
Yes
Entry I_OngoingTaxLitigationsOrDisputes1
Current Status
Status of notice pertaining to FY 2021-22 to 2023-24 (Amount involved - ₹4,36,78,720): • The Company submitted its reply on 27-08-2025. • The opposing party issued a Show Cause Notice dated August 29, 2025, rejecting the Company’s submissions. • The Company submitted its reply to the Show Cause Notice on November 20, 2025. • The Company received an order dated December 17, 2025 wherein the opposing party rejected company’s arguments. • Aggrieved by the impugned order, the Company has filed its appeal under Section 107(1) of the CGST Act, 2017 on March 17, 2026. Status of notice pertaining to FY 2024-25 (Amount involved - ₹3,44,89,344): • The Company submitted its reply on 27-08-2025. • The opposing party issued a Show Cause Notice dated November 20, 2025, rejecting the Company’s submissions. • The Company is yet to file its response to the said Show Cause Notice.
Date of Initiation
25-Aug-2025
Opposing Party
The Joint Director, Directorate General of Goods & Services Tax Intelligence, Belagavi Zonal Unit
Status (Previous Disclosure)
The Company has received a communication from the Directorate General of GST Intelligence (DGGI), Belagavi Zonal Unit, regarding alleged ineligible availment of Input Tax Credit (ITC) on services availed in connection with its Initial Public Offering (IPO) during FY 2021-22 to 2023-24 and 2024-25. The authority has indicated that such expenses relate to the issue of shares, which is considered a non-GST supply, and has advised payment of tax, interest, and penalty aggregating to ₹3,44,89,344 and ₹4,36,78,720 or submission of a representation by 27.08.2025. The Company is in the process of examining the matter and will take appropriate action in due course.
Entry MainD
Whether Part E Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Updates To Ongoing Tax Litigations Or Disputes Is Applicable To The Entity
Yes
Reason For Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Not Applicable To The Entity
There are no reportable events during the quarter.
Whether Part D Of Annexure I Of The SEBI Circular Dated31December2024Related To Disclosure Of Imposition Of Fine Or Penalty Is Applicable To The Entity
No